Why Research Happens in Phases
Part of Understanding Cancer Trials: How cancer trials are organized.
About 3 minutes. Free, in your language, no account needed.
This is general education about clinical research — not medical advice, and not a way to join a study. Talk to your own doctor about your situation.
Research on a new treatment is done in stages. These stages are called phases.
The phases are numbered 1, 2, 3 and 4. Each phase asks a different question, and each one is usually larger than the one before.
Why not test everything at once
The order exists to limit how many people are exposed to an unknown before it is understood.
A new treatment starts as an idea supported by laboratory work. Nobody yet knows how a human body will handle it. So the first study in people is small and watched very closely. If it raises no serious problems, the next study can be a little larger, and can begin to ask a different question.
Each phase narrows the uncertainty before more people are involved.
What each phase is asking
Very broadly:
- Phase 1 asks about safety and dose. How does the body handle it? What side effects appear? What amount can be given?
- Phase 2 asks whether there are early signs that it does something useful against the disease, while continuing to watch safety.
- Phase 3 compares it against the current standard treatment, usually in a much larger group, to see which works better.
- Phase 4 continues after a treatment is approved, looking at long-term safety and how it behaves in wider, more varied groups of people.
The US National Cancer Institute describes typical sizes as roughly 15 to 30 people in phase 1, 50 to 100 in phase 2, and from 100 to several thousand in phase 3. These are typical ranges, not rules, and studies vary.
The phases are not a ladder of quality
It is tempting to read the numbers as a score, where a higher number means a better treatment. That is not what they mean.
The number describes which question is being asked, not how promising something is. A phase 3 study is not testing a better treatment than a phase 1 study. It is testing a treatment that has already been through the earlier questions, so a different question can now be asked about it.
Many treatments do not get past phase 1 or phase 2. That is the system working as designed. Finding out early that something does not work, or is not safe enough, is a real result.
Where the phases blur
You may see labels like "phase 1/2" or "phase 2/3". These are studies that run two stages together, often to save time when a disease is serious and answers are needed sooner.
You may also see studies with no phase number at all, particularly studies about screening, prevention, surgery, radiotherapy, or quality of life. Those do not always follow the same pattern, because the pattern was designed around testing medicines.
If you are ever looking at a specific study, the phase number is a fair thing to ask about. So is what that phase means for that particular study — not phases in general, but that one.
In short
- Research happens in numbered phases so that fewer people meet an unknown before it is understood.
- Phase 1 asks about safety and dose. Phase 2 asks about early signs of effect. Phase 3 compares against standard treatment. Phase 4 continues after approval.
- The phase number describes the question being asked, not how good a treatment is.
- Not every study fits the pattern, and some studies combine phases.